San Diego, CA, United States of America

Quanticel Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 10


Forward Citations = 131

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Jeffrey Alan Stafford (9 out of 143 patents)

silverMedal James Marvin Veal (8 out of 104 patents)

bronzeMedal Zhe Nie (5 out of 47 patents)

4.  Toufike Kanouni (5 out of 86 patents)

5.  Young K Chen (4 out of 63 patents)

6.  Michael Brennan Wallace (4 out of 94 patents)

7.  Stephen W Kaldor (2 out of 68 patents)

8.  Amogh Boloor (2 out of 33 patents)

9.  Michael John Bennett (2 out of 11 patents)

10.  Michael Brennen Wallace (2 out of 2 patents)

11.  Juan Manuel Betancort (1 out of 19 patents)


10 patents:

Company Overview
Quanticel Pharmaceuticals, Inc. is a biotechnology company based in San Diego, California, focused on developing innovative therapies for cancer treatment. The company specializes in harnessing advanced technologies to identify and target cancer stem cells, aiming to improve patient outcomes through precision medicine. Quanticel's research efforts are centered on understanding the complexities of tumor biology, which positions it at the forefront of cancer research and therapeutic development.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

10 Patents

#534 in San Diego, CA

#7,121 in California

#29,892 in US

#56,119 in the World

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 131

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Quanticel Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/quanticel-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…